A study projects up to three Ebola-infected people could be on overseas flights each month from the three most-affected African countries. WSJ's Gautam Naik reports. Photo: Getty

CLICK HERE - The Lancet - Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak

wsj.com - by Gautam Naik - Oct. 20, 2014

Up to three Ebola-infected people could embark on overseas flights every month from the three most-affected African countries, according to a new study that projected travel patterns based on infection rates and recent flight schedules.

The findings, published Monday in the journal Lancet, suggest that Ebola cases could be spread overseas by unwitting travelers from the worst-hit countries—Guinea, Liberia and Sierra Leone.

The World Health Organization has estimated that, by early December, there could be as many as 10,000 new cases a week in west Africa.

DEUTSCHE  WELLE                                                                             Oct. 21, 1914

 By Philipp Sandner and Ibrahima Bah

West African countries that have escaped the Ebola outbreak intend to stay free of it by preparing for the worst. It is a strategy that can work as events in Senegal and Nigeria have shown. 

Mali, Senegal, Ivory Coast and Guinea-Bissau are countries that border on the epicenter of the Ebola epidemic that encompasses Guinea, Liberia and Sierra Leone. All these nations wish to protect themselves.

A health worker takes the temperature of man entering Mali from Guinea

One of the more obvious measures is to screen people entering the country. "We are using thermal imaging cameras to detect people at airports and borders who are running a temperature," said Malian physician Adamas Daou. He works at Mali's National Action Center for the fight against Ebola. Medical personnel are also on duty urging Malians to practice good personal hygiene. "This includes washing their hands in chlorinated water" Daou said.

UPDATE: Drugmakers to join forces to make millions of Ebola vaccine doses

REUTERS                                                                     Oct 22, 2014

By Ben Hirschler

LONDON -- Leading drugmakers plan to work together to speed up the development of an Ebola vaccine and hope to produce millions of doses for use next year.

U.S. firm Johnson & Johnson said on Wednesday that it aims to produce at least 1 million doses of its two-step vaccine next year and has already discussed collaboration with Britain's GlaxoSmithKline, which is working on a rival vaccine.

The economics of an Ebola vaccine are still unclear but drug companies with an eye on their reputations are under pressure to respond to the major international health crisis now ravaging one of the poorest corners of Africa.

NEW YORK TIMES                         Oct. 21, 2014

Op-ed in Today's New York Times by Karen Huster, a nurse working in Liberia for Last Mile Health says that Liberia’s dysfunctional transportation system is standing in the way of fighting the Ebola epidemic and suggests some solutions
 

"Patients have died on grueling journeys to treatment units. Blood samples have sat waiting for days, eventually becoming invalid....

 "The best solution is removing the need to travel altogether by building more easily accessible treatment centers all over the country, where patients with confirmed or suspected cases of Ebola can be housed and treated. The United States military is building these structures, but it is taking time. Nimbler nongovernmental organizations must also step in. Save the Children has already done so and is also building smaller community care centers — sort of homes away from home, where families can continue to care for their sick loved ones safely removed from the community. A makeshift center with tents instead of permanent structures could be set up within a week.